Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

NCT00577421 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT00577421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00577421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO
Lead sponsor
Warner Chilcott
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
January 31, 2006
Enrollment
32 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis